Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.330
+0.080 (3.56%)
At close: Oct 5, 2026, 4:00 PM EDT
2.290
-0.040 (-1.72%)
After-hours: Oct 5, 2026, 7:30 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $129.02 million as of October 5, 2026. Its market cap has decreased by -3.70% in one year.
Market Cap
129.02M
Enterprise Value
-1.45M
1-Year Change
-3.70%
Ranking
Category
Stock Price
$2.33
ChartMarket Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $129.02M, a decrease of -96.06%. That is a compound annual growth rate of -42.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 129.02M | 25.33% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 132.00M |
| Atrium Therapeutics | 131.20M |
| Kazia Therapeutics | 127.58M |
| Caribou Biosciences | 127.04M |
| enGene Therapeutics | 127.00M |
| Tenaya Therapeutics | 126.24M |
| NRx Pharmaceuticals | 121.14M |
| Foghorn Therapeutics | 119.96M |